메뉴 건너뛰기




Volumn 71, Issue 1, 2003, Pages 456-464

Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: Demonstration of efficacy in vivo

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUTAMATE AMMONIA LIGASE; ISONIAZID; METHIONINE SULFOXIMINE; SECRETORY PROTEIN;

EID: 0037221028     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.456-464.2003     Document Type: Article
Times cited : (75)

References (16)
  • 1
    • 0035937258 scopus 로고    scopus 로고
    • An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase
    • Anderson, D. H., G. Harth, M. A. Horwitz, and D. Eisenberg. 2001. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase. J. Mol. Biol. 307:671-681.
    • (2001) J. Mol. Biol. , vol.307 , pp. 671-681
    • Anderson, D.H.1    Harth, G.2    Horwitz, M.A.3    Eisenberg, D.4
  • 2
    • 0031007903 scopus 로고    scopus 로고
    • Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis
    • Belisle, J. T., V. D. Vissa, T. Sievert, K. Takayama, P. J. Brennan, and G. S. Besra. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422.
    • (1997) Science , vol.276 , pp. 1420-1422
    • Belisle, J.T.1    Vissa, V.D.2    Sievert, T.3    Takayama, K.4    Brennan, P.J.5    Besra, G.S.6
  • 3
    • 0031021203 scopus 로고    scopus 로고
    • Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD Global Surveillance Project
    • Cohn, D. L., F. Bustreo, M. C. Raviglione, and the International Union Against Tuberculosis and Lung Disease. 1997. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin. Infect. Dis. 24(Suppl. 1):S121-S130.
    • (1997) Clin. Infect. Dis. , vol.24 , Issue.SUPPL. 1
    • Cohn, D.L.1    Bustreo, F.2    Raviglione, M.C.3
  • 4
    • 0001609466 scopus 로고
    • The relative effect of methionine sulfoximine on different animal species
    • Gershoff, S. N., and C. A. Elvehjem. 1951. The relative effect of methionine sulfoximine on different animal species. J. Nutr. 45:451-458.
    • (1951) J. Nutr. , vol.45 , pp. 451-458
    • Gershoff, S.N.1    Elvehjem, C.A.2
  • 5
    • 0017804058 scopus 로고
    • Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions
    • Griffith, O. W., and A. Meister. 1978. Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions. J. Biol. Chem. 253:2333-2338.
    • (1978) J. Biol. Chem. , vol.253 , pp. 2333-2338
    • Griffith, O.W.1    Meister, A.2
  • 6
    • 0033519232 scopus 로고    scopus 로고
    • An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets
    • Harth, G., and M. A. Horwitz. 1999. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets. J. Exp. Med. 189:1425-1435.
    • (1999) J. Exp. Med. , vol.189 , pp. 1425-1435
    • Harth, G.1    Horwitz, M.A.2
  • 7
    • 0028136469 scopus 로고
    • Glutamine synthetase of Mycobacterium tuberculosis: Extracellular release and characterization of its enzymatic activity
    • Harth, G., D. L. Clemens, and M. A. Horwitz. 1994. Glutamine synthetase of Mycobacterium tuberculosis: Extracellular release and characterization of its enzymatic activity. Proc. Natl. Acad. Sci. USA 91:9342-9346.
    • (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 9342-9346
    • Harth, G.1    Clemens, D.L.2    Horwitz, M.A.3
  • 8
    • 0030959144 scopus 로고    scopus 로고
    • High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets
    • Harth, G., B.-Y. Lee, and M. A. Horwitz. 1997. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect. Immun. 65:2321-2328.
    • (1997) Infect. Immun. , vol.65 , pp. 2321-2328
    • Harth, G.1    Lee, B.-Y.2    Horwitz, M.A.3
  • 9
    • 0034602726 scopus 로고    scopus 로고
    • Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamine/glutamate cell wall structure, and bacterial replication
    • Harth, G., P. C. Zamecnik, J.-Y. Tang, D. Tabatadze, and M. A. Horwitz. 2000. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamine/glutamate cell wall structure, and bacterial replication. Proc. Natl. Acad. Sci. USA 97:418-423.
    • (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 418-423
    • Harth, G.1    Zamecnik, P.C.2    Tang, J.-Y.3    Tabatadze, D.4    Horwitz, M.A.5
  • 10
    • 0037180534 scopus 로고    scopus 로고
    • Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology
    • b. Harth, G., M. A. Horwitz, D. Tabatedze, and P. C. Zamecnik. 2002. Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: proof of principle by using antisense technology. Proc. Natl. Acad. Sci. USA 99:15614-15619.
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 15614-15619
    • Harth, G.1    Horwitz, M.A.2    Tabatedze, D.3    Zamecnik, P.C.4
  • 11
    • 0028950982 scopus 로고
    • Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis
    • Horwitz, M. A., B.-W. E Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92: 1530-1534.
    • (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 1530-1534
    • Horwitz, M.A.1    Lee, B.-W.E.2    Dillon, B.J.3    Harth, G.4
  • 12
    • 0034610299 scopus 로고    scopus 로고
    • Recombinant BCG vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
    • Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslega-Galic. 2000. Recombinant BCG vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97:13853-13858.
    • (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 13853-13858
    • Horwitz, M.A.1    Harth, G.2    Dillon, B.J.3    Maslega-Galic, S.4
  • 13
    • 0029033862 scopus 로고
    • Mitochondrial changes associated with glutathione deficiency
    • Meister, A. 1995. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1271:35-42.
    • (1995) Biochim. Biophys. Acta , vol.1271 , pp. 35-42
    • Meister, A.1
  • 16
    • 0012293539 scopus 로고
    • The methionine sulfoximine syndrome in the cat
    • Proler, M., and P. Kellaway. 1962. The methionine sulfoximine syndrome in the cat. Epilepsia 3:117-130.
    • (1962) Epilepsia , vol.3 , pp. 117-130
    • Proler, M.1    Kellaway, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.